Shibing Tang, Ph.D.

Affiliations: 
2006-2011 School of Chemistry and Chemical Engineering State key laboratry of applied organic chemistry, Lanzhou University 
 2011-2017 Gladstone Institute of Cardiovascular Disease University of California, San Francisco / Gladstone Institutes 
 2017- Center for Chemical Biology and Drug Discovery Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences 
Area:
Medicinal chemistry, Drug discovery, Chemical biology
Google:
"Shibing Tang"
Bio:

• ~20 years combined working experience in Organic Chemistry, Medicinal Chemistry, and Chemical Biology related to Cancer, cardiovascular diseases, bone diseases, etc.
• Excellent tracking record for scientific achievements encompassing 30+ peer-reviewed publications and 8+ patents.
• Outstanding collaborative and interdisciplinary skills with demonstrated ability to work productively in the matrix environment with multi-functional disciplinary teams.

Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wu T, Li ST, Ran Y, et al. (2023) Mapping protein direct interactome of oxidoreductases with small molecular chemical cross-linkers in live cells. Redox Biology. 61: 102642
Tan J, Liu H, Huang M, et al. (2020) Small molecules targeting RORγt inhibit autoimmune disease by suppressing Th17 cell differentiation. Cell Death & Disease. 11: 697
Hou L, Yang G, Tang S, et al. (2018) Small Molecule Derived From Carboxyethylpyrrole Protein Adducts Promotes Angiogenesis in a Mouse Model of Peripheral Arterial Disease. Journal of the American Heart Association. 7: e009234
Qin Y, Tang S, Zhen G, et al. (2018) Bone-targeted delivery of TGF-β type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati-Engelmann disease. Annals of the New York Academy of Sciences
Yang B, Tang S, Ma C, et al. (2017) Spontaneous and specific chemical cross-linking in live cells to capture and identify protein interactions. Nature Communications. 8: 2240
Nakamura PA, Shimchuk AA, Tang S, et al. (2017) Small molecule Photoregulin3 prevents retinal degeneration in the Rho(P23H) mouse model of retinitis pigmentosa. Elife. 6
Xie M, Tang S, Li K, et al. (2017) Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine. Accounts of Chemical Research
Nie B, Nie T, Hui X, et al. (2017) Brown Adipogenic Reprogramming Induced by a Small Molecule. Cell Reports. 18: 624-635
Nakamura PA, Shimchuk AA, Tang S, et al. (2017) Author response: Small molecule Photoregulin3 prevents retinal degeneration in the RhoP23H mouse model of retinitis pigmentosa Elife
Nakamura PA, Tang S, Shimchuk AA, et al. (2016) Potential of Small Molecule-Mediated Reprogramming of Rod Photoreceptors to Treat Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science. 57: 6407-6415
See more...